%0 Journal Article
%9 ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES
%A Camlin, C.S.
%A Seeley, J.
%A Viljoen, L.
%A Vernooij, E.
%A Simwinga, M.
%A Reynolds, L.
%A Reis, R.
%A Plank, R.
%A Orne-Gliemann, J.
%A McGrath, N.
%A Larmarange, Joseph
%A Hoddinott, G.
%A Getahun, M.
%A Charlebois, E.D.
%A Bond, V.
%T Strengthening universal HIV 'test-and-treat' approaches with social science research
%D 2016
%L fdi:010066573
%G ENG
%J AIDS
%@ 0269-9370
%K AFRIQUE
%M ISI:000371905500019
%N 6
%P 969-970
%R 10.1097/QAD.0000000000001008
%U https://www.documentation.ird.fr/hor/fdi:010066573
%> https://horizon.documentation.ird.fr/exl-doc/pleins_textes/divers16-03/010066573.pdf
%V 30
%W Horizon (IRD)
%X Strengthening universal HIV 'test-and-treat' approaches with social science research The recent publication of new WHO guidelines, including a call for antiretroviral therapy for everyone diagnosed with HIV regardless of CD4 þ cell count and preexposure prophylaxis for people at substantial risk of HIV infection [1], marks an important moment for taking stock of what will be needed to take biomedical HIV prevention approaches to scale, and sustain them. As the author of a recent editorial in The Lancet [2] observes, these guidelines are 'welcome but ambitious. [.. .] No studies exist that address how such a strategy can be executed on a global scale' (p. 1420). We, a multidisciplinary group of social scientists working as part of five large-scale 'universal test-and-treat' (UTT) trials being implemented across six African countries, would argue that successful large-scale expansion of treatment and preexposure prophylaxis will require an indepth understanding of the heterogeneous community and health systems' contexts of the rollout.
%$ 056